Covid Vaccine Updates and General Discussion About Vaccines

Will you take a Covid vaccine once one is approved and deemed safe and effective by the FDA?

  • Yes, stick me please

  • No, I will wait

  • No, I will never take one


Results are only viewable after voting.

MisterPenguin

President of Animal Kingdom
Premium Member
110M by end of March for both shots unless JnJ gets approved then likely 140-150M fully vaccinated.
For end of March, I have in millions:
  • Pfizer: 120 doses / 60 people
  • Moderna: 100 doses / 50 people
  • J&J: 100 doses / 100 people

From your link:

“I do know that J&J is making a very large supply, going all out with its production, both here in the U.S. and elsewhere around the world, with the goal of having perhaps enough vaccines for 100 million Americans by spring, by this April or so,” said McClellan.​
 

CastAStone

5th gate? Just build a new resort Bob.
Premium Member
As for herd immunity, it seems increasingly evident that for the S. African variant, vaccines don’t work as well
I agree with your premise that we should move the goalposts to serious illness, not any illness. But I think we could consider avoiding the phrase “vaccines don’t work” in any context until while we’re still trying to convince people to vaccinate.
 

ToTBellHop

Well-Known Member
I agree with your premise that we should move the goalposts to serious illness, not any illness. But I think we could consider avoiding the phrase “vaccines don’t work” in any context until while we’re still trying to convince people to vaccinate.
That’s why I said they “don’t work as well.” And that is certainly true. None of the vaccines do.

The average person doesn’t understand herd immunity. Focus on, “all of these vaccines provide tremendous protection against severe illness or death from COVID-19.“

We need simple messaging.
 

ToTBellHop

Well-Known Member
Boosters targeting the new variants are already in the works.

If we can keep the sheer amount of new cases down, there will be fewer and fewer variants, making contact tracking and targeting with updated boosters more effective.
Yes, and if we are lucky, they’ll start coming out in the fall and it will take a year to vaccinate the world against the S. African strain. New variants will develop in that time.

It really isn’t possible to eradicate illnesses like this. Look at flu.
 

correcaminos

Well-Known Member
Yes, and if we are lucky, they’ll start coming out in the fall and it will take a year to vaccinate the world against the S. African strain. New variants will develop in that time.

It really isn’t possible to eradicate illnesses like this. Look at flu.
We cannot compare to the flu even this way. Some vaccines are effective against the S African variant. We actually have a shot at eliminating the virus.
 

GoofGoof

Premium Member
Original Poster
That’s why I said they “don’t work as well.” And that is certainly true. None of the vaccines do.

The average person doesn’t understand herd immunity. Focus on, “all of these vaccines provide tremendous protection against severe illness or death from COVID-19.“

We need simple messaging.
I don’t know about not working well. We have no evidence that the Pfizer and Moderna vaccines don’t work well against the S African variant. We know in a limited study the AstraZenneca one isn’t effective. We also know that JnJ had a site in S Africa for their trial and while the efficacy was lower than in the US it was still north of 50% effective against even mild infection and 85% effective in preventing severe infection.
 

GoofGoof

Premium Member
Original Poster
Yes, and if we are lucky, they’ll start coming out in the fall and it will take a year to vaccinate the world against the S. African strain. New variants will develop in that time.

It really isn’t possible to eradicate illnesses like this. Look at flu.
For the world, it’s going to take a while. Pfizer and Moderna can produce a booster that is highly effective vs whatever variant is the flavor of the week this summer/fall. They could easily delivery enough doses for every American to get the booster this Fall or Winter. That wouldn’t be the worst outcome. For the world we really need AstraZenneca and JnJ to vaccinate places without cold storage. There are other options on the table too. JnJ was already discussing altering their formula to be more effective against the S African variant too. Many of the doses delivered outside of the US, UK, EU we’re not expected until summer of Fall so there’s time to alter them to fight these variants.
 

correcaminos

Well-Known Member
I'm going to get ready for my upcoming Moderna shot #2 in 2 weeks with no planned activities for me immediately after the shot. My neighbors received Moderna shot #2 several days ago and experienced severe chills, arm pain and fatigue for 2 days.
I was just at the dentist today talking about this. There seems to be no rhyme or reason to who gets it worst. Though most there seemed okay with arm pain mostly. I hope the same for you!
 

danlb_2000

Premium Member
I was just at the dentist today talking about this. There seems to be no rhyme or reason to who gets it worst. Though most there seemed okay with arm pain mostly. I hope the same for you!

I would be interesting to know if there is correlation with how people react to the seasonal flu vaccine. I personally have never had even the slightest reaction to that vaccine, but I know others who have.
 

GoofGoof

Premium Member
Original Poster
I would be interesting to know if there is correlation with how people react to the seasonal flu vaccine. I personally have never had even the slightest reaction to that vaccine, but I know others who have.
My boss got his first shot on Saturday and was still feeling the effects today. He gets a flu shot every year and said he’s never had a reaction outside of a sore arm. He said Saturday was just a sore arm but then woke up yesterday feeling a little off and then got chills and flu like symptoms that were still going on today.
 

danlb_2000

Premium Member
K, thanks.

Update...

Here's what I got so far (in millions):
  • Pfizer: 300 doses (150 people vaccinated). End of March, 120 doses. End of May (originally end of June), 100 doses. End of Summer, 100 doses.
  • Moderna: 300 doses (150 people vaccinated). End of March, 100 doses. End of May (originally end of June), 100 doses. End of Summer, 100 doses.
  • Astrazeneca/Oxford: 150 doses (75 people vaccinated). End of May, 75 doses. End of Summer, 75 doses.
  • Novavax: 110 doses (55 people vaccinated). End of May, 110 doses.
  • J&J: 200 doses (an extra 100 was ordered) which is 200 people vaccinated (only 1 dose needed). End of March, 60 doses. End of June, 40 doses. End of Summer, 100 doses.
That is a total of 715 people vaccinated. Twice the population of the U.S.


Timeline in adults vaccinated and percentage of all adults:
  • End of March: 210 adults vaccinated. 68% of all adults.
  • End of May: 280 more adults vaccinated for a total of 490 theoretical adults vaccinated. 159% of all adults.
  • End of Summer: 225 more adults vaccinated for a total of 715 theoretical adults vaccinated. 231% of all adults.

We could hit herd immunity by the end of March. Certainly by the end of April unless the three other vaccines never get approved.

Do you know the rough breakdown of Pfizer/Moderna administered in the US? I am asking because I was looking at the VAERS data the Pfizer shows dramatically more adverse reaction reports then the Moderna. Wondering if that is just due to a difference in how many doses were administered or if it is an actual difference in reaction between the two.
 

GoofGoof

Premium Member
Original Poster
Do you know the rough breakdown of Pfizer/Moderna administered in the US? I am asking because I was looking at the VAERS data the Pfizer shows dramatically more adverse reaction reports then the Moderna. Wondering if that is just due to a difference in how many doses were administered or if it is an actual difference in reaction between the two.
CDC site has it now:
C0704228-E122-4B4E-92E1-2825B1C36B43.png
 

danlb_2000

Premium Member

Interesting. Here is current data from VAERS, the adverse event tracking data, from the US. This data is voluntarily reported, not vetted, and there is no analysis to determine if the event was actually caused by the vaccine, so it's not the best quality data, but the numbers are still interesting. Dramatic difference between the two vaccines. There is also a big difference between the sexes. When looking at the seasonal flu data I see a similar distribution, but not in the MMR vaccine.

1612834149453.png
 
Last edited:

GoofGoof

Premium Member
Original Poster
Interesting. Here is current data from VAERS, the adverse event tracking data, from the US. This data is self reported, not vetted, and there is no analysis to determine if the event was actually caused by the vaccine, so it's not the best quality data, but the numbers are still interesting. Dramatic difference between the two vaccines. There is also a big difference between the sexes. When looking at the seasonal flu data I see a similar distribution, but not in the MMR vaccine.

View attachment 530569
Interesting. I wonder if it’s demographic based too. Pfizer needs a deeper freezer and came out sooner so maybe has been more focused on hospitals and larger medical centers with the proper equipment. Since healthcare workers skew younger (and more female) maybe a more robust immune response. If Moderna has been used in more mass vaccination sites and pharmacy rollouts maybe skews a little older demographic so maybe less robust immune response. I have no facts to support that assumption, just a pure guess based on what we know of the rollouts. In the trials the adverse reactions seemed pretty close to the same so it seems odd to have that large a disparity.

On the gender bias I would have assumed men would have had more recorded events since my wife says we tend to be big babies when sick and complain about everything;););)
 

danlb_2000

Premium Member
Interesting. I wonder if it’s demographic based too. Pfizer needs a deeper freezer and came out sooner so maybe has been more focused on hospitals and larger medical centers with the proper equipment. Since healthcare workers skew younger (and more female) maybe a more robust immune response. If Moderna has been used in more mass vaccination sites and pharmacy rollouts maybe skews a little older demographic so maybe less robust immune response. I have no facts to support that assumption, just a pure guess based on what we know of the rollouts. In the trials the adverse reactions seemed pretty close to the same so it seems odd to have that large a disparity.

On the gender bias I would have assumed men would have had more recorded events since my wife says we tend to be big babies when sick and complain about everything;););)

The Pfizer being administered in a health care setting may also have led to more reporting of adverse events.
 

Register on WDWMAGIC. This sidebar will go away, and you'll see fewer ads.

Back
Top Bottom